GlaxoSmithKline plc (GSK.L)

1.343,80 +10,60 (+0,80%) Börsenschluss: 4:35PM BST

GlaxoSmithKline plc

980 Great West Road
Brentford TW8 9GS
United Kingdom
44 20 8047 5000
http://www.gsk.com

Sektor(en): Healthcare
Branche: Drug Manufacturers—General
Vollzeitmitarbeiter: 99.437

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Ms. Emma N. Walmsley	CEO & Director	3,29M	1,6M	1970
Mr. Iain James Mackay	CFO & Exec. Director	2,36M	N/A	1962
Dr. Hal V. Barron	Chief Scientific Officer, Pres of R&D and Director	6,34M	N/A	1963
Ms. Karenann K. Terrell	Chief Digital & Technology Officer	N/A	N/A	1961
Ms. Sarah Elton-Farr	Head of Investor Relations	N/A	N/A	N/A
Mr. Nick Hirons	Sr. VP of Global Ethics & Compliance	N/A	N/A	N/A
Mr. James Ford	Sr. VP & Gen. Counsel	N/A	N/A	N/A
Ms. Sally Jackson	Sr. VP of Global Communications & CEO Office	N/A	N/A	N/A
Ms. Diana Conrad	Sr. VP of HR	N/A	N/A	N/A
Mr. David Simon Redfern	Chief Strategy Officer	N/A	N/A	1966

Die Beträge haben den Stand 31. Dezember 2019 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in GBp.

Beschreibung

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Corporate Governance

GlaxoSmithKline plcs ISS Governance QualityScore, Stand 6. Oktober 2020, lautet 6. Die grundlegenden Scores sind Audit: 1, Vorstand: 2, Shareholderrechte: 1, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.